Cutaneous Chemical Carcinogenesis: Past, Present, And Future  by Yuspa, Stuart H. et al.
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY , 67:199-208 , 1976 
Copyright © 1976 by The Williams & Wilkins Co . 
Vol. 67, No . 1 
Printed in U.S.A . 
CUTANEOUS CHEMICAL CARCINOGENESIS: PAST, PRESENT, AND FUTURE 
STUART H. YUSPA, M.D., HENRY HENNINGS , PH.D., AND UMBERTO SAFFIOTTI, M.D. 
In Vitro Pathogenesis Section, Experimental Pathology Branch (Carcinogenesis), Division of Cancer Cause and 
Prevention, National Institutes of Health, Bethesda, Maryland, U. S. A. 
Skin tumors chemically induced in mice have provided an important experimental model 
for studying carcinogenesis and for bioassaying carcinogenic agents. The information obtained 
from this model suggests that the events leading to tumor formation can be divided into at 
least two stages, initiation and promotion. A single small dose of carcinogen produces initia-
tion which appears to be irreversible. These initiating agents may have to be metabolically 
activated and can 'interact with cellular macromolecules. The extent to which they bind to 
DNA correlates well with their carcinogenicity. Increased DNA replication at the time of or 
during the first day after these agents have been applied appears to enhance carcinogenesis. 
Unlike initiation, promotion appears to be reversible and the promoting agents must be ap-
plied repeatedly before tumors are formed. Promoters interact with membranes, stimulate 
and alter genetic expression, and increase the rate of cell proliferation. 
The knowledge gained from these studies in mouse skin has immeasurably helped the entire 
field of chemical carcinogenesis. But efforts to determine the cellular and molecular mecha-
nisms involved in the carcinogenic process, particularly in the skin, have been hampered by 
the difficulties of working on whole animals and by the special problems associated with the 
biologic and biochemical methods required for this target organ. Such problems, however, 
can be solved by the use of cell cultures of mouse epidermis which can metabolize and bind 
carcinogens just as is done in vivo. The fact that epidermal cells in vitro proliferate syn-
chronously should facilitate the study of the relation between the cell cycle and carcinogene-
sis. These cells repair chemically induced DNA damage by at least two mechanisms, excision 
repair and base-specific repair. When epidermal cells in vitro are exposed to promoting 
agents, a proliferative response analogous to that in vivo is elicited, apparently mediated 
through control of polyamine metabolism. Neoplastic transformation has been induced in 
these cultures by known skin carcinogens. 
Cutaneous carcinogenesis has been the proto-
type model for studying the chemical induction of 
cancer in human populations and in experimental 
animals. For over 60 years, since the first reports 
that repeated applications of coal tar produced 
epidermal tumors on the ears of rabbits [1], the 
skin has been used to assay and study the biologic 
response to chemical carcinogens. The isolation of 
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benzo [a ]pyrene (BP) from coal tar [2] and the 
synthesis of dibenzanthracene (DBA), methylchol-
anthrene (MeA) , and dimethylbenzanthracene 
(DMBA) [3-5] in the 1930s facilitated the induc-
tion of epidermal tumors in mouse skin, and 
" painting" the skin with carcinogens became the 
principal method of studying the mechanisms of 
chemical carcinogenesis. As a result of these stud-
ies, the distinct stages of chemical carcinogenesis 
were defined as initiation and promotion [6]. 
Several extensive reviews and monographs on 
the advances in cutaneous carcinogenesis since 
that time have been published recently [7-12). We 
shall not review the advances in photocarcinogene-
sis [13] and tumorigenesis evoked by other physical 
or viral agents [14,15] but shall limit our discussion 
to chemical carcinogenesis. We shall also omit 
discussion of the important advances in synthetic 
and analytical chemistry which have supplied 
experimental oncology with the chemical methods 
and tools to study the mechanisms of tumor 
initiation [16-18] and promotion [19,20] . We will 
narrow our discussions to epidermal carcinogenesis 
in the mouse. Chemicals can induce skin tumors in 
other species as well, e.g., melanomas in hamsters 
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and guinea pigs [21-23], and the study of strain and 
species sensitivity to cutaneous chemical carcino-
genesis has provided much useful information 
[24,25]. Since anticarcinogenesis [26], that is the 
inhibition of carcinogenesis or its reversion back to 
a normal morphology as a result of vitamin A and 
related synthetic compounds (retinoids), has been 
recently reviewed by Bollag [27] and by Sporn, 
Dunlop, Newton, and Smith [28], we shall only 
mention it here. 
The two stages of skin carcinogenesis are clearly 
illustrated by the data of Boutwell who used mice 
bred for sensitivity to the process [7]. No tumors 
were induced in mice painted with 25 I-Lg of the 
initiator DMBA at zero time, and only a few 
papillomas occurred after 24 weeks of treatment 
with croton oil applied at a 1 % concentration in 
benzene twice weekly. However, when DMBA was 
followed in 1 week by biweekly application of 
croton oil, all of the mice developed papillomas 
within the relatively short period of 12 weeks, 
much faster than most other experimental tumor 
induction systems. Malignant tumors began to 
appear around 24 weeks, and about half the 
animals developed carcinomas in less than a year. 
To achieve such sharply contrasting effects under 
these test conditions, these workers used a subcar-
cinogenic dose, usually less than 100 I-Lg, for the 
single application of DMBA. A single application 
of more than 100 I-Lg DMBA produced some tumors 
after several months [29]. Repeated applications of 
low doses of DMBA (5-25 I-Lg) produce multiple 
papillomas and carcinomas, an indication that 
complete carcinogens have both initiating and 
promoting properties. 
INITIATION 
In 1949 Berenblum and Shubik showed that the 
initiated state was maintained for 43 weeks and 
suggested that it is irreversible [30]. Boutwell [7] 
confirmed this finding. An identical tumor re-
sponse, with respect to the time promotion was 
started, was found in 3 groups treated in the 
following ways: (1) DMBA initiation at zero time 
followed 1 week later by croton oil promotion; (2) 
DMBA initiation at 15 weeks followed by croton oil 
promotion at week 16; and (3) DMBA initiation at 
zero time followed 16 weeks later by croton oil 
promotion. Thus, the change in the epidermal cells 
brought about by the initiator appeared to be a 
permanent one. Van Duuren et al [31] have re-
cently shown that even after a lag of up to 56 weeks 
between initiator and promoter, the tumor re-
sponse is comparable to that in age-matched 
controls treated without such a lag. Their data also 
show that young mice are more susceptible than 
old mice. Roe et al [32] recently reported that the 
tumor yield in mice that had been allowed to age 
after initiation and then treated with the promot-
ing agent was lower than in younger mice, but by 
omitting the necessary age-matched controls for 
initiation they failed to provide relevant data 
crucial for testing the persistence of initiation. In a 
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recent, well-controlled study (F. Stenback and P. 
Shubik, personal communication), mice were al-
lowed to age 70 weeks between initiation and 
promotion and were then compared with mice 
initiated at 70 weeks of age. The fact that both 
groups had comparable numbers of tumors by 95 
weeks once again demonstrated that the initiated 
state is permanent. 
The irreversibility of initiation suggests that the 
conversion of a normal cell to a tumor cell must 
involve alterations in the genetic information 
which controls cell growth and differentiation. The 
altered tumor phenotype may result from changes 
in the genetic material (DNA) or may reflect 
epigenetic effects [33] in the form of altered RNA 
and protein molecules. In either event, the cova-
lent or physical binding of a chemical carcinogen to 
critical molecular sites in the cell is probably 
related to the mechanism of neoplastic transforma-
tion. 
The study of how chemical carcinogens interact 
with mouse skin macromolecules began nearly 25 
years ago when Miller reported that benzopyrene 
was firmly bound to mouse skin proteins [34]. All 
carcinogens examined since then have been found 
to bind to mouse skin DNA and RNA as well as to 
soluble and insoluble proteins [8,35]. The impor-
tance of DNA binding in carcinogenesis was em-
phasized by Brookes and Lawley, who reported 
that the extent of carcinogen binding to whole skin 
DNA was well correlated with the carcinogenic 
activity of a series of 8 carcinogenic hydrocarbons 
[36,37]. Such a correlation was not found for 
binding to RNA or protein. This relation was 
confirmed by Goshman and Heidelberger [38] with 
the notable exception of DBA. Of particular impor-
tance was their finding that the specific binding to 
DNA from epidermis was greater than that to DNA 
from whole skin. Recent data from Slaga, Scribner, 
and Rice [39] suggest that the physical, noncova-
lent interaction between carcinogens and cell mac-
romolecules, particularly cytosol receptor proteins, 
is important for the promoting action of these 
compounds. 
The diversity of the chemical agents that initiate 
skin tumors ranges from the directly active alkylat-
ing agents like IJ-propiolactone (BPL) to the poly-
cyclic aromatic hydrocarbons like BP and DMBA 
which must be metabolically activated to interact 
with cellular macromolecules (Fig. 1). These hy-
drocarbons are metabolized from their original 
form (procarcinogen) to a reactive form (ultimate 
carcinogen, an electrophilic reactant which in-
teracts with cellular nucleophiles, like the nucleo-
tides in DNA and RNA or the S - in methionine or 
cysteine in proteins) by an enzyme system known 
as aryl hydrocarbon hyroxylase (AHH), which 
consists of a group of mixed-function oxidases 
found in the skin and in other target organs for 
carcinogenesis [40,41]. This group of enzymes both 
detoxifies and activates the polycyclic hydrocar-
bons administered to mice. Gelboin, Kinoshita, 
and Wiebel [25] showed that the level of AHH 
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FIG. 1. Some chemicals which initiate tumor forma-
tion in mouse skin. 
inducible in the skin of different mouse strains 
generally correlates with their susceptibility to 
skin tumorigenesis by polycyclic hydrocarbons. 
The lack of a clear linear relation , however, sug-
gests that more complex mechanisms than simple 
activation are involved. One such complicating 
factor which affects the relation between metabo-
lism and carcinogenicity, is probably the profile of 
metabolic products [18,25,42]. 
Recently Wiebel, Leutz, and Gelboin [43] have 
shown that the highest level of induced AHH was 
found in the upper layer of the dermis where the 
sebaceous glands are located and the lowest level 
in the deeper layers of the dermis. Enzyme activity 
in the epidermis was intermediate between the high 
and low dermal levels. The complex relation be-
tween metabolism and carcinogenesis is illustrated 
by the finding that 7,8-benzoflavone, an inhibitor 
of AHH induction, decreases skin carcinogenicity 
and macromolecular binding by DMBA but in-
creases skin carcinogenicity and does not affect 
DNA binding by BP [44,45]. In addition, Watten-
berg and Leong [46] found that 5,6-benzoflavone, 
an enzyme inducer, protects against BP-induced 
skin carcinogenesis. Thus, there is little doubt 
that metabolic activation is fundamentally impor-
tant in skin carcinogenesis but its specific role 
needs to be clarified. 
Early studies had shown that cell proliferation is 
involved in skin carcinogenesis [47-49]. In initia-
tion-promotion experiments, the increased rate of 
cell proliferation induced by pretreating mice with 
croton oil or other hyperplastic agents before the 
application of DMBA or urethane resulted in a 
higher tumor incidence but did not alter the extent 
of covalent binding of the initiator to DNA [50]. 
We used a single croton oil application at various 
times before and after initiation with urethane to 
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study the role of increased cell proliferation in 
initiation [51] . When croton oil was given 24 or 6 hr 
before or 1 hr after a urethane injection, the 
incidence of tumors tripled (Fig. 2). Croton oil 
stimulates DNA synthesis but only after an inter-
val of 12 to 15 hr [51]. The kinetics of response were 
similar when croton oil was given in conjunction 
with urethane as initiator (Fig . 3). Thus , DNA 
replication up to 15 hr after urethane administra-
tion (when most of the urethane has been elimi-
nated from the animal) seems to be as important 
for tumor initiation as replication is at the time of 
urethane administration. This suggests that DNA 
replication after its interaction with the initiator 
but before this interaction is modified is important 
in initiation. 
Some of what we have learned about initiation 
can be briefly summarized. The process can be 
accomplished by a single small dose of carcinogen. 
The initiated cells are irreversibly altered since 
they respond to croton oil promotion equally well 
at long or short intervals after initiation. Initiators 
interact with cellular macromolecules but some 
need to be metabolically activated. The irreversi-
bility of the process and the positive correlation 
between the extent of binding to DNA and carcino-
genicity in a series of polycyclic hydrocarbons 
suggest that DNA interaction and the subsequent 
genetic alteration are important. Increased replica-
tion while the carcinogen is bound may also be 
important in initiation. 
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FIG. 2. Effects of a croton oil application on urethane 
initiation of skin tumorigenesis in CD-l female mice. At 
times indicated before and after ip injection of 1 mg/gm 
body weight urethane solution (0 time), 0.5% (v/v) croton 
oil in acetone was applied topically. Four weeks later 
weekly treatments with croton oil were begun and con-
tinued for 30 weeks. Papillomas per mouse at 30 weeks 
= the total number of papillomas in each group divided 
by the number of surviving mice and expressed as the 
percent of the control group which did not receive cro-
ton oil at the time of initiation. 
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FIG. 3. DNA synthesis in CD-1 female mouse epider-
mis after a single administration of urethane or urethane 
plus croton oil. Urethane (1 mg/gm body weight) was 
injected ip at zero time. Croton oil (0 .5% in acetone) was 
applied topically either 6 hr before or 1 hr after urethane. 
[3H]TdR (30 ,uCi/mouse) was injected ip 1 hr before 
sacrifice at the indicated times. Nucleic acid hydroly-
sates were prepared from acetic acid-separated epidermis 
and the specific activity of epidermal DNA was deter-
mined for each group. 
PROMOTION 
Skin tumor formation is promoted by several 
diverse agents, some of which are shown in the 
Table . Croton oil and the phorbol esters isolated 
from croton oil such as 12-0-tetradecanoyl phor-
bol-13-acetate (TPA) are the strongest known 
promoters [52] and have been widely used in 
studies ' of the 2-stage mechanism of skin car-
cinogenesis. The only obvious features common to 
all of the promoting agents listed are the irritation, 
inflammation, and hyperplasia produced when 
they are applied to mouse skin. 
Several workers have stressed that cell prolifera-
tion is important in promotion [53-55]. The find-
ing that wound healing promotes tumor formation 
[54,56] supports this view. In mouse skin, in which 
tumors were initiated with a single dose of DMBA, 
the healing of a 4- to 5-cm wound closed with 
wound clips elicited both papillomas and carcino-
mas along the wound line [54]. However, promo-
tion involves more than just an induced increase in 
cell proliferation since several strong hyperplastic 
agents such as cantharidin, ethyl phenyl propio-
late, and acetic acid are very weak tumor pro-
moters [54,57-59]. 
Unlike initiators, which produce a permanent 
change in the potential cell phenotype, individual 
doses of promoters cause cellular changes which 
are transient and reversible. For every given dose of 
a promoting agent, an optimum frequency of 
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application must be found [7,54]. If this frequency 
is reduced, the effectiveness of the promoting agent 
is decreased or lost. An exeriment designed to test 
this phenomenon [54] showed that the maximum 
yield of both papillomas and carcinomas was 
identical when croton oil was given either once or 
twice per week but was reached 4 weeks earlier 
when the promoter was applied twice per week. 
When the same total dose of croton oil was given 
every other week, the maximum yield of papillo-
mas and carcinomas was reduced and papillomas 
developed more slowly; when given once every 4 
weeks to the same total dose, no tumors developed 
[7]. Similar results have been reported by Frei 
[60] and by van Duuren et al [61]. 
Results from several laboratories during the past 
10 years have indicated that several parameters of 
genetic expression can be stimulated by treatment 
with tumor promoters [9]. A single application of 
croton oil stimulated nucleic acid and protein 
synthesis in mouse skin. Maximum rates of RNA 
synthesis were reached at 6 hr, of protein synthesis 
at 12 hr, and of DNA synthesis at 18 hr [54]. 
Similar results have been obtained with TPA and 
other tumor promoters [62,63] . In addition to 
stimulating macromolecular synthesis, tumor pro-
moters alter cell membranes [64,65] and phospho-
lipid metabolism [66], stimulate the phosphoryla-
tion of epidermal histones [67], and alter epider-
mal differentiation [68]. Which of these effects are 
most relevant to skin tumor formation has not been 
determined. 
In summary, the data on promoters suggest that 
their immediate action is reversible and that 
repeated applications are needed to promote tumor 
formation. Promoters interact with membranes, 
stimulate and alter genetic expression, and eventu-
ally increase the rate of cell proliferation; one or 
more of these interactions is probably responsible 
for their mechanism of action. 
CELL CULTURE METHODS AND MECHANISM STUDIES 
The difficulties of performing biochemical proce-
dures in skin, coupled with the biologic complica-
tions of working in the whole animal, have hin-
dered progress in defining the molecular changes 
involved in chemical carcinogenesis. During the 
TABLE. Promoting agents for mouse skin 
Croton oil and phorbol esters (tetradecanoyl phorbol-ace-
tate, TPA) 
Phenol and related compounds 
Anthralin 
Tween 60 
Iodoacetic acid 
1-Fluoro-2, 4-dinitrobenzene 
Orange oil (limonene) 
Wound healing 
Cantharidin 
Ethyl phenyl propiolate 
Acetic acid 
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last 4 or 5 years, therefore, several groups, includ-
ing our own, have adapted methods of culturing 
mouse epidermal cells to develop a better system 
in which to examine the mechanisms of car-
cinogenesis. Cell culture has several advantages for 
these types of studies. Variations in chemical 
exposure from cell to cell and biologic variations 
from animal to animal have been virtually elimi-
nated. If metabolism is to occur, it must be present 
in the cultured cell. Systemic effects are elimi-
nated, and biochemical manipulations and evalua-
tions are facilitated. Of course, this artificial sys-
tem has certain limitations. First, the validity of 
the results obtained in vitro must be determined. 
Second, adequate criteria for recognizing the trans-
formed state of cells in vitro must be established, 
but so far this has been difficult in epithelial cells 
[69,70]. Finally, since cells in culture sometimes 
undergo spontaneous malignant transformation, it 
is necessary to determine whether treatment and 
results are causally related [71]. 
We have modified a trypsin-flotation method 
first described by Szabo [72] to isolate epidermal 
cells from newborn BALB/c mice [73]. These cells 
have histochemical and morphologic (including 
ultrastructural) characteristics similar to those of 
epidermal cells in vivo [73]. During part of their 
lifespan in vitro, these cells produce an amorphous 
product which is histochemically similar to mouse 
keratin [73]. A method was developed to graft 
these cultured cells back onto the surgically ex-
posed panniculus carnosus on the dorsum of syn-
geneic mice where donor epidermal sheets formed 
within 2 to 4 weeks [74]. Similar grafting results 
have also been reported by Worst, Valentine, and 
Fusenig for the mouse [75] and by Karasek for the 
rabbit [76]. 
This system of culturing mouse epidermal cells 
has some disadvantages, however, since the cells 
have a limited lifespan in vitro. If cell density is 
measured as total DNA per dish as a function of 
time in culture , the density values in this system 
decrease rather than increase, presumably because 
of maturation, even though proliferation continues 
[77]. On the other hand, this system provides the 
opportunity to study, by appropriate manipula-
tions of the target cells, those factors which, at 
least in in vivo studies, seem to be important for 
carcinogenesis: cell kinetics, metabolism, re-
sponse to promoters, and recognition of altered 
states of differentiation and growth control. 
The control of cell growth kinetics was studied in 
our laboratory by Kjell Elgjo [78] who demon-
strated by both autoradiographic and biochemical 
techniques with pulse-labeled [3H ]thymidine 
( [3H ]TdR) that these cultures have a natural cell 
cycle synchrony whose peaks of DNA synthesis 
occur about 20 hr apart, starting at 20 hr after 
culture (Fig. 4). Mitotic peaks were also shown to 
occur approximately 9 to 12 hr after the synthesi$ 
peaks. Further studies used a continuous [3H ]TdR 
label to demonstrate that this pattern was the 
result of a single cohort of cycling cells which 
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FIG. 4. [3H ]TdR labeling index of cell cultures of the 
epidermis of neonate mice. Epidermal cells growing in 
glass chamber slides were pulsed for 1 hr with [3H ]TdR 
(1 jlCi/ml) at the indicated times. Mter fixation and 
preparation of autoradiograms, labeled cells were 
counted among 1000 cells. (Reprinted with permission of 
The Journal of Investigative Dermatology ) 
represented about 70% of the attached population 
at its maximum. With this in vitro system, the 
effects of chemicals on the cell cycle could be 
studied without further manipulation. 
For an in vitro system to produce useful results 
regarding chemical carcinogen effects, the target 
cells must have the right enzyme systems to 
metabolically activate the carcinogens. That this is 
particularly important in cutaneous chemical car-
cinogenesis is shown by the fact that so many of the 
in vivo experiments used polycyclic aromatic hy-
drocarbons. One way to measure metabolism, in 
vitro and in vivo, is to assay the AHH system [25]. 
During their first several days in culture, epider-
mal cells have easily measurable levels of AHH 
[77]; moreover, when the cells are exposed to 3 
.ug/ml benzanthracene (BA) for 20 hr before har-
vest and assay, enzyme activity increases 12- to 
l5-fold. After the cells have been cultured for 10 
days, the activity of both the constitutive and 
ind uced enzymes decreases significantly. However, 
this decline can be prevented by adding 1.25% 
dimethyl sulfoxide (DMSO) to the growth me-
dium. How DMSO effects this result is not under-
stood, but Yuspa and Harris [73] observed that 
this level of DMSO in the medIUm prolongs the 
lifespan of these cultures. Similar results were 
achieved when metabolic activation was measured 
by exposing the cells to [l4C ]DMBA and studying 
the covalent binding of DMBA to epidermal DNA 
[77]. Carcinogen binding is 2 to 4 times greater in 
3-day-old cells than in 10-day-old cells and DMSO 
in the medium increases binding in older cells. To 
effect this increase, DMSO must be present during 
the entire culture period, not just during carcino-
gen exposure. Thus the increased uptake ofDMBA 
in the presence of the solvent cannot be responsible 
for the higher binding. 
Since covalent binding of carcinogens to DNA 
occurs in culture, one can s~udy whether the 
increased binding of carcinogens to replicating 
DNA is responsible for the increased tumorigenic-
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ity observed when initiators are applied during 
stimulated proliferation. Our results for DMBA 
clearly showed that binding to DNA was not 
increased when DNA was in the replicative phase 
[79]. In addition, in this cell culture system, DNA 
which had the carcinogen bound to it was still 
functioning as a template for new DNA synthesis; 
moreover, the DNA strand to which the carcinogen 
was attached was carried over into the daughter 
cell [80]. Replication of DNA to which carcinogen 
is bound may lead to altered base pairing, lending 
support to the somatic mutation theory of car-
cinogenesis. Thus, cell proliferation at the time of 
initiation may serve to fix a mutagenic event. 
Another kind of DNA-carcinogen interaction is 
believed to be important in chemical carcinogene-
sis. The cell's ability to repair the DNA damage 
caused by chemicals may be protective if the repair 
is accurate and efficient or harmful if the repair is 
error prone. Repair of DNA damage is biochemi-
cally demonstrable by the incorporation of radioac-
tively labeled DNA precursors into nonreplicating 
DNA. In cell culture systems. replicating DNA can 
be separated from nonreplicating DNA by density 
labeling the former with the heavy precursor bro-
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modeoxyuridine (BrUdR) and centrifuging both 
species through an isopycnic density gradient of 
CsCI [79]. Using these techniques, Hennings and 
co-workers have demonstrated that epidermal 
cells in vitro can repair DNA damage caused by 
high doses of the skin carcinogens, N-methyl-N'-
nitro-N-nitrosoguanidine (MNNG) and BPL [81, 
82]. This kind of repair, the cut-and-patch type 
[83], incorporates radioactive DNA precursor into 
light density nonreplicating DNA [84]. However, 
since the high doses of MNNG and BPL used to 
induce excision repair are highly toxic, cell survival 
is minimal [82]. Lower doses of MNNG, such as 1 
and 5 ,ug/ml, not only ensure cell survival [82] but 
are within the range which had induced neoplastic 
transformation for other in vitro systems [85]. It is 
significant that at these doses (Fig. 5) repair can be 
effected only when the specific precursor represent-
ing the major DNA site attacked by the carcino-
gen, which for MNNG is guanine, is used. In this 
experiment, after treatment with 5 ,ug/ml MNNG 
for 1 hr only, the specific target precursor 
[3H ]deoxyguanosine ([3H ]GdR) was incorporated 
into light, nonreplicating DNA whereas [3H ]TdR 
was not. This base-specific repair has not been 
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demonstrated in human cells but is present in 
mouse epidermal cells, mouse dermal fibroblasts, 
and rat whole-skin cultures. Whether it plays a role 
in carcinogenesis remains to be determined. 
The studies on carcinogen metabolism , binding, 
and DNA repair indicate that epidermal cell cul-
tures are useful for investigating the events impor-
tant for initiation. It should also be useful for 
studying tumor promotion. All promoters have in 
common the ability to stimulate proliferation [9]. 
DNA synthesis, measured as the incorporation of 
[3H]TdR into DNA after a I-hr pulse label, was 
stimulated 5-fold 72 to 96 hr after various doses of 
the active croton oil derivative TP A had been 
applied to epidermal cells in culture (Fig. 6) [86]. 
This response was dose dependent and was ob-
tained even after a TPA treatment of only 1-hr 
duration. The stimulation was preceded by an 
inhibition of synthesis for 24 hr. The maximum 
response was observed when the cells were treated 
after 24 hr in culture, a time when many cells are in 
G1 (Fig. 4). Proliferating fibroblast cultures derived 
from mouse dermis were not stimulated by TPA. 
The chemically related nonpromoter, phor-
bol-13,20-diacetate, had no effect on DNA synthe-
sis in epidermal or dermal cell cultures (unpub-
lished data). Thus epidermal cells in vitro respond 
to promoter as expected. Sivak and Van Duuren 
[87] and Sivak [88] showed that TPA in culture 
medium stimulates RNA synthesis and releases 
contact inhibition in 3T3 cells, a mouse fibroblast 
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strain. Recently Mondal, Peterson, and Brankow 
[89] have reported that a line of C3H mouse 
fibroblasts, particularly susceptible to in vitro 
transformation, were induced to proliferate by 
TP A. These same cells can be transformed in vitro 
by exposure to low, normally nontransforming 
doses of polycyclic hydrocarbons when the latter 
are followed by exposures to TP A. 
The facility with which epidermal cultures can 
be used to study changes at the cellular level 
prompted us to investigate how promoting agents 
act. The demonstration that ornithine decarboxvl-
ase (ODC), the first enzymatic step in the synthe-
sis of polyamines, was stimulated under conditions 
which induce proliferation [90] led Lichti and 
Yuspa to study the role of this enzyme in TPA-
induced proliferation (unpublished data). ODC 
activity in epidermal cells peaks 12 hr after plating 
and by 20 hr it is extremely low and stays at this 
level for at least 80 hr. When cells cultured for 24 hr 
are exposed to TPA, ODC activity increases 10-fold 
and peaks 8 hr after exposure. This response, like 
that of stimulated DNA synthesis, reaches its 
maximum if the cells are treated after 24 hr in 
culture. A 10-min pulse with TPA is sufficient to 
induce a maximal stimulation at the susceptible 
time. Thus ODC appears to be involved in the 
proliferative response induced by promoters. Dur-
ing the course of these in vitro studies, O'Brien, 
Simsiman, and Boutwell [91] reported similar 
results after the application of TP A to mouse skin 
III VlVO. 
The development of an in vitro model has thus 
been very useful in the study of skin carcinogene-
sis . The system is suitable for investigating the 
cellular events involved in initiation and promo-
tion . Epidermal cells have beell transformed into 
malignant cells in vitro by chemical carcinogens, 
but so far these results have been obtained only by 
the use of mass culture systems and the end points 
were not quantitative [92,93]. A clonal assay with 
quantitative parameters must be developed before 
the epidermal culture system can attain its max-
imum potential. We are confident that the infor-
mation about initiation and promotion recently 
acquired from these studies in vitro, combined 
with more than 30 years' experience obtained from 
the in vivo systems for skin carcinogenesis, will 
stimulate the development of improved model 
systems and will deepen our understanding of skin 
carcinogenesis and its possible prevention . 
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